Module Development and New Distribution Partnership Aim to Integrate
MTWA with Standard Stress Test Systems and Drive Broad Use
Cambridge Heart, Inc. (OTCBB: CAMH Stock News),...
Cambridge Heart, Inc. (OTCBB: CAMH), today reported total revenue of
$2,191,000 for the quarter ended December 31, 2007, compared to total
revenue of $2,223,000 for the same period...
Cambridge Heart, Inc. (OTCBB: CAMH) announced today that the Board of Directors has promoted Ali Haghighi-Mood, Ph.D., to the position of Chief Executive Officer. Dr. Haghighi-Mood...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH), today announced a three-year exclusive sales and marketing agreement with St. Jude Medical, Inc. (NYSE:STJ), under...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH), today reported total revenue of $2,223,100 for the quarter ended December 31, 2006, an increase of 104%, compared to...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH) today announced revenue and gross
margin guidance for 2007. Based on a more favorable reimbursement
environment, a...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH) today announced that as of December
15, 2006 the Board of Directors accepted the resignation of Jeffery J.
Langan...
#46: CAMH News Largest Prospective Study of Microvolt T-Wave Alternans Demonstrates This Technology's Predictive Value for Sudden Cardiac Death in Patients With Preserved Left Ventricular Function After Acute Myocardial Infarction
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH) announced today the publication of a
study in the Journal of the American College of Cardiology
assessing the...
#45: CAMH News Results of Clinical Trial Demonstrate That a New, Non-invasive Test is Comparable to Invasive Tests in Identifying Patients Who Could Benefit from ICDs
CHICAGO--(BUSINESS WIRE)--New clinical trial results from the Alternans Before Cardioverter
Defibrillator (ABCD) trial were presented today at the American
Heart Association’s...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH) today announced that WellPoint/Anthem
has revised its Coverage Policy Bulletin (MED.00041) on Microvolt T Wave ...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH) today announced that Healthcare
Service Corporation (“HCSC”)
has revised its Coverage Policy Bulletin...
#42: CAMH News Results from St. Jude Medical's Study of Microvolt T-Wave Alternans to be Presented at the 2006 American Heart Association Scientific Sessions
ST. PAUL, Minn., and BEDFORD, Mass.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) and Cambridge Heart, Inc. (OTCBB:CAMH)
today announced that the findings of the Alternans Before...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH) today reported total revenue of
$2,030,600 for the quarter ended September 30, 2006, an increase of
$1,113,300, or...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH) announced today that its President
and CEO, Mr. Jeff Langan, will present at the CIBC World Markets 17th
Annual...
BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH) announced today that Laurence
Blumberg, MD has joined the Company’s Board of
Directors increasing the number...
